69 related articles for article (PubMed ID: 969438)
1. [Blood groups and malignant tumor morbidity].
Zhivetskiĭ AV; Andrusenko VA; Bodnar' GV
Vrach Delo; 1976 Jun; (6):107-9. PubMed ID: 969438
[No Abstract] [Full Text] [Related]
2. [Malignant tumors and ABO blood groups--an analysis of 10,258 patients with malignant tumors].
Wan DS
Zhonghua Zhong Liu Za Zhi; 1984 Nov; 6(6):435-8. PubMed ID: 6532747
[No Abstract] [Full Text] [Related]
3. Relationship of ABO blood groups to certain types of cancer common in Western India.
Jayant K
Indian J Cancer; 1971 Sep; 8(3):185-8. PubMed ID: 5141723
[No Abstract] [Full Text] [Related]
4. [Distribution of ABO blood groups in patients with carcinoma of the larynx, uterus, and with multiple neoplasms according to the records of the Department of Radiotherapy in the years 1960-1971].
Kukolewska-Machnicka J
Pol Przegl Radiol Med Nukl; 1973; 37(3):433-8. PubMed ID: 4720251
[No Abstract] [Full Text] [Related]
5. Distribution of blood groups in cancer.
Ghooi AM; Kamalpuria SK; Jain PK; Tandon PL
Indian J Cancer; 1970 Dec; 7(4):296-305. PubMed ID: 5518060
[No Abstract] [Full Text] [Related]
6. [Blood groups ABO, RHo(D) factor and the life expectancy of patients with malignant tumors].
Pejchl S; Chaloupka F
Vnitr Lek; 1984 Apr; 30(4):351-5. PubMed ID: 6428045
[No Abstract] [Full Text] [Related]
7. Malignant neoplasms and ABO blood groups--a short report.
Rahim MA; Rahman MH; Shahidullah M; Sarma SK
Bangladesh Med Res Counc Bull; 1979 Dec; 5(2):81-2. PubMed ID: 551768
[No Abstract] [Full Text] [Related]
8. [ABO blood groups and malignant neoplasms].
Voĭtenko VP; Poliukhov AM; Kolodchenko VP; Rudakova NI
Genetika; 1977; 13(1):165-7. PubMed ID: 612480
[No Abstract] [Full Text] [Related]
9. [Is there a correlation between ABO blood groups, duodenal ulcer and some malignant diseases?].
Pazur M
Lijec Vjesn; 1973 Dec; 95(12):691-3. PubMed ID: 4775533
[No Abstract] [Full Text] [Related]
10. [Blood group studies in malignant neoplastic diseases].
Hartmann E; Rex-Kiss B
Ann Immunol Hung; 1973; 17():193-203. PubMed ID: 4218934
[No Abstract] [Full Text] [Related]
11. [Frequency of the ABO and Rheusus blood group system in peptic ulcer and malignant neoplasms].
Peleshchuk AP; Nikula TD; Kushniruk IuI
Vrach Delo; 1971 Jun; (6):26-8. PubMed ID: 4999236
[No Abstract] [Full Text] [Related]
12. ABO blood group distribution in relation to malignancies in Egypt.
Hammouda F; Soliman HA; Hussein MH
J Egypt Med Assoc; 1972; 55(8):655-60. PubMed ID: 4664110
[No Abstract] [Full Text] [Related]
13. [Determination of blood groups and serum groups in patients with carcinoma].
Scholz W; Gilly L; Gilly G
Strahlentherapie; 1968 Oct; 136(4):448-53. PubMed ID: 4179780
[No Abstract] [Full Text] [Related]
14. Blood groups in cancer in Assam.
Baruah BD; Gogoi BC
Indian J Cancer; 1977 Mar; 14(1):6-9. PubMed ID: 885570
[No Abstract] [Full Text] [Related]
15. The ABO blood groups and cancer.
Lee YT
Surg Gynecol Obstet; 1971 Jun; 132(6):1093-7. PubMed ID: 4931132
[No Abstract] [Full Text] [Related]
16. [ABO blood groups in physicians of 75 years of age. Further evidence in favor of little more fitness on the part of subjects with blood group O].
Jörgensen G
Minerva Med; 1974 Jul; 65(54):2881-6. PubMed ID: 4546500
[No Abstract] [Full Text] [Related]
17. Relationship between ABO blood groups and skin cancers.
Tursen U; Tiftik EN; Unal S; Gunduz O; Kaya TI; Camdeviren H; Ikizoglu G
Dermatol Online J; 2005 Dec; 11(3):44. PubMed ID: 16409940
[TBL] [Abstract][Full Text] [Related]
18. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.
Streiff MB; Segal J; Grossman SA; Kickler TS; Weir EG
Cancer; 2004 Apr; 100(8):1717-23. PubMed ID: 15073862
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between the blood-groups ABO and Rho (D) factor and the frequency of malignant liver metastases (author's transl)].
Pejchl S; Chaloupka F
Cesk Gastroenterol Vyz; 1981 May; 35(3):105-11. PubMed ID: 6793244
[No Abstract] [Full Text] [Related]
20. Pretreatment determination of isohaemagglutinin titter values in patients with malignant lymphomas and metastatic solid tumors.
Nikolić L; Budisin Z; Jelić S
Med Sci Monit; 2000; 6(1):63-7. PubMed ID: 11208285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
